These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7488300

  • 1. Effect of (Z)-11-[3-(dimethylamino) propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride on experimental allergic conjunctivitis and rhinitis in rats and guinea pigs.
    Kamei C, Sugimoto Y, Nakamura S, Zhong C.
    Arzneimittelforschung; 1995 Sep; 45(9):1005-8. PubMed ID: 7488300
    [Abstract] [Full Text] [Related]

  • 2. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA.
    J Ocul Pharmacol Ther; 1996 Sep; 12(4):389-400. PubMed ID: 8951675
    [Abstract] [Full Text] [Related]

  • 3. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
    Pipkorn P, Costantini C, Reynolds C, Wall M, Drake M, Sanico A, Proud D, Togias A.
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
    [Abstract] [Full Text] [Related]

  • 4. [The effect of KW-4679, an antiallergic drug, on experimental allergic rhinitis].
    Kaise T, Manabe H, Ohmori K.
    Arerugi; 1995 Oct; 44(10):1229-33. PubMed ID: 8579485
    [Abstract] [Full Text] [Related]

  • 5. Effect of KW-4679, an orally active anti-allergic drug, on antigen-induced airway hyperresponsiveness in actively sensitized guinea pigs.
    Kawasaki H, Manabe H, Ohmori K.
    Jpn J Pharmacol; 1996 Mar; 70(3):277-80. PubMed ID: 8935723
    [Abstract] [Full Text] [Related]

  • 6. Effects of antiallergic agents including levocabastine on experimental rhinitis in rats.
    Tasaka K, Kamei C, Nakamura S.
    Arzneimittelforschung; 1994 Mar; 44(3):337-41. PubMed ID: 7514877
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
    Ohmori K, Hayashi K, Kaise T, Ohshima E, Kobayashi S, Yamazaki T, Mukouyama A.
    Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
    [Abstract] [Full Text] [Related]

  • 8. [Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis].
    Murata T, Matsumoto Y, Suzuki T, Naito K, Takata I, Tsuzurahara K.
    Arerugi; 1997 Jul; 46(7):576-84. PubMed ID: 9301130
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [Abstract] [Full Text] [Related]

  • 10. Effect of the new antiallergic agent olopatadine on EEG spectral powers in conscious rats.
    Kamei C, Ichiki C, Izumo T, Ohishi H, Yoshida T, Tsujimoto S.
    Arzneimittelforschung; 1996 Aug; 46(8):789-93. PubMed ID: 9125280
    [Abstract] [Full Text] [Related]

  • 11. Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.
    Ohmori K, Hasegawa K, Tamura T, Miyake K, Matsubara M, Masaki S, Karasawa A, Urayama N, Horikoshi K, Kajita J, Hasegawa M, Taniguchi K, Komada T, Kawamoto Y.
    Arzneimittelforschung; 2004 Aug; 54(12):809-29. PubMed ID: 15646365
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM, Tekelioglu Y, Turk A, Akyol N.
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [Abstract] [Full Text] [Related]

  • 13. Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat.
    Schoch C.
    Ocul Immunol Inflamm; 2005 Feb; 13(1):39-44. PubMed ID: 15804768
    [Abstract] [Full Text] [Related]

  • 14. Antigen (DNP-As)-induced allergic rhinitis model in guinea pigs.
    Ishida M, Amesara R, Ukai K, Sakakura Y.
    Ann Allergy; 1994 Mar; 72(3):240-4. PubMed ID: 7510462
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV, Udell IJ.
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [Abstract] [Full Text] [Related]

  • 16. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A, Quintieri L.
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
    Berdy GJ, Spangler DL, Bensch G, Berdy SS, Brusatti RC.
    Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
    Tamura T, Kimoto N.
    Pharmacology; 2009 Jul; 84(5):288-93. PubMed ID: 19816088
    [Abstract] [Full Text] [Related]

  • 19. [Effect of KW-4679, an antiallergic drug, on antigen-induced airway microvascular leakage in rats passively sensitized with mouse monoclonal IgE antibody].
    Ohmori K, Ishii H, Sasaki Y.
    Arerugi; 1996 Apr; 45(4):393-7. PubMed ID: 8687287
    [Abstract] [Full Text] [Related]

  • 20. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
    Yamasaki M, Matsumoto T, Fukuda S, Nakayama T, Nagaya H, Ashida Y.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.